卵巢癌球体的大小和形状对耐药性和迁移的影响
研究用OVCAR-3和OVCAR-8细胞形成疏松聚集体与紧密球体,检测上皮-间质转化标志物,并给予紫杉醇和顺铂处理。结果显示耐药性不随球体大小和形状变化,而紧密球体(OVCAR-8)的迁移能力比疏松聚集体(OVCAR-3)高15倍。
要点
- OVCAR-3形成疏松聚集体,OVCAR-8形成紧密球体,形态差异与上皮-间质转化标志物表达有关。
- 耐药性未随球体大小和形状变化而出现差异。
- 紧密球体(OVCAR-8)迁移能力比疏松聚集体(OVCAR-3)高15倍。
核心结论
- 球体大小和形状影响抗癌药物耐药性和迁移特征,结果有助于阐明基于3D样本的卵巢癌研究的一般规律。
研究设计与样本
- 用OVCAR-3和OVCAR-8细胞形成球体,以共聚焦显微镜和荧光显微镜监测形态,用蛋白质印迹法检测上皮-间质转化标志物E-钙黏蛋白、波形蛋白和Slug,并用紫杉醇和顺铂处理球体后研究迁移特征。
主要发现
- 观察到两种不同的多细胞结构:疏松聚集体(OVCAR-3)和紧密球体(OVCAR-8)。
- 不同形态归因于上皮-间质转化标志物的表达及其在球体形成后的变化。
- 未观察到耐药性随球体大小和形状变化而出现差异。
- 紧密球体(OVCAR-8)的迁移能力比疏松聚集体(OVCAR-3)高15倍。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High fatality in ovarian cancer is attributed to metastasis, propagated by the release of multi-cellular aggregates/spheroids into the peritoneal cavity and their subsequent mesothelial invasion of peritoneal organs. Spheroids are therefore a common and clinically relevant in vitro model for ovarian cancer research. Spheroids in patients vary significantly in size and shape and display enhanced resistance to anti-cancer drugs compared to monolayers. However, there is no consensus on how spheroid size and shape affect drug resistance. Moreover, existing data regarding the influence of epithelial-to-mesenchymal transition (EMT) profile on spheroid shape and migration is inconclusive. METHODS: We formed spheroids with OVCAR-3 and OVCAR-8 cells, chosen for their established genetic similarity to the patient tumor samples. We monitored their morphology using confocal microscope with dipping objective and fluorescent microscope. We characterized important EMT biomarkers; E-cadherin, Vimentin and Slug through western blotting in monolayers and spheroids. We treated these spheroids with Taxol and Cisplatin and investigated their migratory profile based on their morphology. RESULTS: We report two distinct multicellular structures: loose aggregates (OVCAR-3) and compact spheroids (OVCAR-8). We attribute these different morphologies to the expression of the EMT biomarkers, and their changes upon spheroid formation. Importantly, we did not observe a difference in resistance to the anti-cancer drugs as a function of spheroid size and shape. However, migration capacity of compact spheroid (OVCAR-8) was 15-fold higher compared to that of loose aggregates (OVCAR-3). CONCLUSIONS: These results highlight the importance of spheroid size and shape on anti-cancer drug resistance and migration profiles. The results of this study can, therefore, help to elucidate general rules for ovarian cancer studies based on 3D samples.
引用
- Gunay G, Kirit HA, Kamatar A, et al. The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration. Gynecol Oncol. 2020. PMID: 32958270. doi:10.1016/j.ygyno.2020.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。